Nalmefene: clinical and real world evidence in the treatment of alcohol dependence

1 Docente di Medicina delle Farmacotossicodipendenze, Universita di Pisa e Responsabile dell’Unita di Doppia Diagnosi “Vincent P. Dole”, Dipartimento di Neuroscienze, Ospedale “S. Chiara” dell’Universita di Pisa; 2 Specialista in Psichiatria; Dottore di Ricerca in Neuropsicofarmacologia Clinica, Universita di Pisa; Perfezionato in Psicopatologia dello Sviluppo, Universita di Pisa; Perfezionato in Farmacologia e Farmacoterapia dei Disturbi d’Ansia, Universita di Siena; 3 Scuola di Psichiatria, Universita di Pisa; 4 Istituto di Psichiatria e Psicologia, Universita Cattolica del Sacro Cuore, Roma; DH di Psichiatria Clinica e Farmacodipendenze, Policlinico Universitario “A. Gemelli”, Roma; 5 Unita di Doppia Diagnosi “Vincent P. Dole” del Dipartimento di Neuroscienze, Ospedale “Santa Chiara”, Universita di Pisa e Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali (AU-CNS), Pietrasanta, Lucca

[1]  Ministero della Salute Direzione generale della prevenzione.  Relazione del Ministero della Salute al Parlamento sugli interventi realizzati ai sensi della legge 30.03.2001 n.125 Legge quadro in materia di alcol e problemi alcolcorrelati , 2014 .

[2]  M. Soyka.  Nalmefene for the treatment of alcohol dependence: a current update. , 2014, The international journal of neuropsychopharmacology.

[3]  D. Nutt.  The role of the opioid system in alcohol dependence , 2014, Journal of psychopharmacology.

[4]  K. Mann,et al.  A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence , 2013, European Neuropsychopharmacology.

[5]  J. V. van Amsterdam,et al.  Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence. , 2013, Journal of psychopharmacology.

[6]  M. Niciu,et al.  Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders , 2013, CNS Drugs.

[7]  W. van den Brink,et al.  Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies , 2013, Alcohol and alcoholism.

[8]  J. Daeppen,et al.  The economic burden of alcohol dependence in Europe. , 2013, Alcohol and alcoholism.

[9]  K. Mann,et al.  Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene , 2013, Biological Psychiatry.

[10]  G. Bakalkin,et al.  Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system , 2012, Front. Mol. Neurosci..

[11]  J. Os,et al.  The size and burden of mental disorders and other disorders of the brain in Europe 2010 , 2011, European Neuropsychopharmacology.

[12]  B. Johnson.  Medication treatment of different types of alcoholism. , 2010, The American journal of psychiatry.

[13]  R. Spanagel.  Alcoholism: a systems approach from molecular physiology to addictive behavior. , 2009, Physiological reviews.

[14]  G. Koob,et al.  Pharmacological Evidence for a Motivational Role of κ-Opioid Systems in Ethanol Dependence , 2008, Neuropsychopharmacology.

[15]  S. Aalto,et al.  Prolonged Central μ-Opioid Receptor Occupancy after Single and Repeated Nalmefene Dosing , 2005, Neuropsychopharmacology.

[16]  C. Gianoulakis.  Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. , 2001, Journal of psychiatry & neuroscience : JPN.

[17]  B. Mason,et al.  A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. , 1999, Archives of general psychiatry.

[18]  P. Emmerson,et al.  Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. , 1994, The Journal of pharmacology and experimental therapeutics.

[19]  B. Weissman,et al.  Binding of a new opiate antagonist, nalmefene, to rat brain membranes. , 1985, Methods and findings in experimental and clinical pharmacology.

[20]  J. Rehm,et al.  The Risks Associated With Alcohol Use and Alcoholism , 2011, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[21]  Guideline on the development of medicinal products for the treatment of alcohol dependence Table of contents , 2010 .

[22]  V. Modesto-Lowe,et al.  The Opioidergic-Alcohol Link , 2005, CNS drugs.

[23]  I. Levav,et al.  The treatment gap in mental health care. , 2004, Bulletin of the World Health Organization.